Your FREE subscription will give you access to articles, research reports, Biopharma CEO Confidence quarterly reports and much more!

Kineticos Senior Team Decades of Experience, Trusted Knowledge

At Kineticos, our senior team consists of life sciences industry professionals with decades of combined experience and highly-diversified backgrounds. With a wealth of knowledge gained from this extensive life science experience, Kineticos delivers significant value to a range of clients seeking trusted strategy consulting services. Below, you will find information and details about the backgrounds, education, and industry experience of our leadership team members.

Shailesh Maingi

Shailesh Maingi - KineticosHeadshot

Mr. Maingi founded Kineticos Life Sciences in 2012 and develops long-term and day-to-day execution strategies.

In addition to serving as CEO of Kineticos, Mr. Maingi is as a Board Observer for Locus BioSciences, a CRISPR gene editing start-up. Mr. Maingi also served on the Board of Directors at Gallus Biopharmaceutical, a biopharmaceutical CMO, and on the Advisory Boards of Novolipid and Enci Therapeutics, two pre-clinical oncology biotechnology start-ups. Mr. Maingi is currently on the Board of Directors at Prevention Partners, a Chapel Hill, NC based non-profit. In addition, Mr. Maingi is Adjunct Faculty at the UNC’s Kenan-Flagler School of Business.

Prior to founding Kineticos Life Sciences, Mr. Maingi was a senior executive at Cardinal Health/PTS and Sigma-Aldrich/Supelco. Mr. Maingi earned a BS in Chemistry from UNC, Chapel Hill and an MBA from Golden Gate University.

Mr. Maingi’s Areas of Expertise:

  • Corporate Strategy and Execution
  • Research and Innovation
  • Business and Corporate Development
  • Process Improvement / Change Management

Bill Finger


Mr. Finger serves as Executive Vice President and Managing Director of Kineticos’ Precision Medicine and Diagnostics practice and brings over 25 years of diagnostic and laboratory experience to the firm.

Prior to joining Kineticos in 2012, Mr. Finger served as the Global Director of Technical Services and Sales Operations at LabCorp Clinical Trials and was responsible for supporting internal customers (sales, operations, companion diagnostics and lab) and external customers (pharma, biotech, and CROs) with both technical and commercial strategies to help support clinical trials. While at LabCorp, Mr. Finger had oversight of Technical Services / Scientific Affairs to include technical lab support and pricing, sales operations, and LIMS globally across the LabCorp network of labs and also managed the preclinical lab, specimen management, and construction of the biorepository. Prior to joining LabCorp, Mr. Finger held various roles of increasing responsibility at Champlain Valley Physicians’ Hospital, Duke Medical Center and Wake Health Services.

Mr. Finger earned his Masters of Healthcare Administration from UNC-Chapel Hill and a BS in Medical Technology from the State University of New York at Plattsburgh.

Mr. Finger’s Areas of Expertise:

  • Precision Medicine
  • Oncology Diagnostics
  • Point of Care
  • Operational Excellence

Mark Osterman

mark2Mr. Osterman, Senior Vice President of Kineticos’ Biopharmaceutical Practice, adds more than 25 years of experience in the biopharmaceutical industry to the team.

Mr. Osterman held roles in sales, clinical, and marketing at GlaxoSmithKline before moving to Johnson & Johnson, where he launched their stem cell internal venture and was responsible for the cardiovascular, pulmonary, metabolic, and mimetibody therapeutic areas in the Global Biologic Strategic Marketing.  Mr. Osterman then served as Senior Vice President responsible for commercial operations and business development at Discovery Labs before accepting a position as Vice President of Global Marketing at Solstice Neurosciences. Immediately prior to joining Kineticos, he founded the Osterman Strategy Group, a boutique management consulting firm, where he worked with large and emerging biopharmaceutical companies to help solve their most challenging business issues.

Mr. Osterman earned a dual BA in Business Management and Economics from North Carolina State University.

Mr. Osterman’s Areas of Expertise:

  • Global Strategic Marketing
  • New Business Development
  • Merger and Acquisition Strategy
  • Organizational and Leadership Development

Glen Martin


Mr. Martin, Senior Vice President of Kineticos’ Biopharmaceutical Practice, adds more than 22 years of experience in the biopharmaceutical industry to the team.

Mr. Martin held roles in sales for several start up biopharma companies before moving to Pharmion, a then-leading global oncology company. While at Pharmion, Mr. Martin held various management roles in sales before moving to Medical Affairs and becoming the National Director of the US Medical Science Liaison program. After Celgene acquired Pharmion in 2008, Glen took on responsibilities as Celgene’s Senior Director, Outcomes Research & Operations. Subsequently, Glen spent 4 years serving in the capacity of Chief of Staff for Celgene’s US Medical Affairs group before being recruited by Covis Pharma, a unique start up company, to serve as Vice President of Oncology Sales. Following the acquisition of Covis, Mr. Martin served as Senior Vice President, Medical Sciences for Ashfield Healthcare.

Mr. Martin earned his BA in Psychology from LaSalle University in Philadelphia, PA.

Mr. Martin’s Areas of Expertise:

  • Oncology
  • Commercial & Medical Affairs Field Deployment Strategy & Management
  • Medical Affairs Strategic Design
  • Medical Affairs Operational Excellence

Bill Dupere

Mr. Dupere brings 30 years of experience in the biopharmaceutical industry to the Kineticos team. He spent 10 years immersed in formative training across core disciplines including clinical research, regulatory affairs, project, communications, and product management at both medical device (CTL, Inc.) and pharmaceuticals (Burroughs Wellcome Co.). He then started ATOM, Inc., a boutique consultancy focused on helping companies–including Lilly, Genentech, Sanofi and others—project manage the commercial launch their first oncology product. Mr. Dupere progressed to start new business units as Vice President of Business Development at LifeMetrix, retained consultant at US Oncology (Market Focus), and Sr. Vice President, Oncology Biopharmaceutical Solutions at Biologics, Inc. More recently, as COO for QOL Medical, he successfully re-positioned and built out an orphan disease company.

Mr. Dupere earned his BS in Public Health and MBA, both from the University of North Carolina at Chapel Hill.

Mr. Dupere’s Areas of Expertise:

  • Product Opportunity Assessment
  • Commercialization Strategy
  • Out-sourcing Integration
  • Patient Access and Optimization

Kevin Hampton


Mr. Hampton serves as Kineticos’ Vice President of Marketing brings over 10 years of sales and marketing of experience to the firm.

Mr. Hampton is responsible for coordinating and managing Kineticos’ thought leadership, brand awareness, and lead generation programs. Additionally, Mr. Hampton provides sales support to the sales function while maintaining an infrastructure that fosters growth. Mr. Hampton is also responsible for ensuring marketing objectives remain aligned with objectives of the firm and its practices.

Mr. Hampton earned his BS degree in Business Management with a Finance concentration from North Carolina State University in Raleigh, NC.


Mr. Hampton’s Areas of Expertise:

  • Thought Leadership Development
  • Campaign Management
  • Lead Generation
  • Project Management

Contact Us Today to Discover How We Can Elevate Your Business Our Strategy Consulting Services Are Designed to Enhance Your Value

Contact Us Today